首页> 美国卫生研究院文献>Frontiers in Immunology >Dickkopf-3 Contributes to the Regulation of Anti-Tumor Immune Responses by Mesenchymal Stem Cells
【2h】

Dickkopf-3 Contributes to the Regulation of Anti-Tumor Immune Responses by Mesenchymal Stem Cells

机译:Dickkopf-3有助于间充质干细胞抗肿瘤免疫反应的调节。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mesenchymal stem cells (MSCs) are known to limit immune responses in vivo by multiple soluble factors. Dickkopf-3 (DKK3), a secreted glycoprotein, has recently been identified as a novel immune modulator. Since DKK3 has been reported to be produced by MSCs, we investigated whether DKK3 contributes to the immune suppression of anti-tumor responses by MSCs. Whereas wild-type MSCs inhibited immune responses against two different transplantation tumors, DKK3-deficient MSCs did not affect the rejection process. Increased CD8+ T cell and reduced M2-type macrophages infiltration was observed in tumors inoculated together with DKK3-deficient MSCs. Thus, DKK3 could alter the composition of the tumor stroma, thereby supporting the MSCs-mediated suppression of immune responses against these tumor transplants.
机译:间充质干细胞(MSC)已知通过多种可溶性因子限制体内免疫反应。 Dickkopf-3(DKK3),一种分泌的糖蛋白,最近被鉴定为新型免疫调节剂。由于据报道DKK3是由MSC产生的,因此我们研究了DKK3是否有助于MSC的抗肿瘤反应的免疫抑制。野生型MSC抑制针对两种不同移植肿瘤的免疫反应,而DKK3缺失的MSC则不影响排斥过程。在与缺乏DKK3的MSC一起接种的肿瘤中,观察到CD8 + T细胞增加,M2型巨噬细胞浸润减少。因此,DKK3可以改变肿瘤基质的组成,从而支持MSCs介导的针对这些肿瘤移植物的免疫反应抑制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号